CMAX

Running trials

• Recruiting

  SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

  NCT07422675· Phase 1· Source

• Recruiting

  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients

  NCT07085507· Phase 1/2· Source

• Recruiting

  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease

  NCT06732180· Phase 1· Source

• Recruiting

  Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D

  NCT06829563· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease2 recruiting
• Multiple sclerosis1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant

  NCT05670379· Phase 1· Source

• Completed

  First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort

  NCT06565208· Early phase 1· Source

• Completed

  A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants

  NCT06363383· Phase 1· Source